Format

Send to

Choose Destination
Clin Rheumatol. 2005 Nov;24(6):661-2. Epub 2004 Dec 2.

Churg-Strauss syndrome and the leukotriene receptor antagonist pranlukast.

Abstract

The authors studied eight cases of Churg-Strauss syndrome (CSS) associated with the use of pranlukast, a common cysteinyl leukotriene receptor antagonist (LTRA) in Japan. The patients who received pranlukast showed significantly increased peripheral blood eosinophil count, neurological disability scores, and poor responses to corticosteroid in comparison with those patients not receiving pranlukast. We suggest that preceding administration of pranlukast aggravates clinical presentations of CSS.

PMID:
15578247
DOI:
10.1007/s10067-004-1035-z
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center